Daily Headlines

PUTTING BREAKING MEDICAL NEWS INTO PRACTICE^™

Thursday May 01, 2008

TODAY'S HEADLINES
Add us to your address book or trusted sender list to help ensure delivery.

Did you know that you can earn CME/CE credit by reading our news reports? Look for the CME designation after the article title.

Personalized Training on Birth Management Guidelines Cuts Complications

BUENOS AIRES -- Birth complications were significantly reduced when physicians and midwives received intensive training in active management of the third stage of labor, researchers here said. full story

http://www.medpagetoday.com/OBGYN/Pregnancy/tb/9288

Survey Is ECG a Plus Before ADHD Therapy?

The American Heart Association has said it’s reasonable to do a baseline ECG before starting children on stimulant therapy for ADHD. Vote

OTHER MEDPAGE TODAY EXTRAS

Blogs

Campaign '08

Focus on Policy

Multimedia

Greener Urban Areas May Reduce Childhood Asthma Rates

NEW YORK -- Young children who live in city neighborhoods with tree-lined streets are less likely to develop asthma, but the actual protective factor remains unknown, researchers said. full story

http://www.medpagetoday.com/AllergyImmunology/Asthma/tb/9282

Campaign ’08: McCain Would Scrap Employer-Based Health Insurance for Open-Market Coverage
TAMPA, Fla. -- In a major speech on health policy, presumptive Republican presidential nominee John McCain reiterated his view that employer-based medical insurance leads to higher health costs and inefficiencies. full story

http://www.medpagetoday.com/PublicHealthPolicy/Campaign08/tb/9294

Genotyping Predicts Risk and Outcome in AML

ULM, Germany -- Genotyping of acute myeloid leukemia can risk-stratify and predict response to treatment in patients with cytogenetically normal leukemic cells, investigators in a European cooperative study group have found. full story

http://www.medpagetoday.com/HematologyOncology/Leukemia/tb/9290

Compound in Grapefruit Impedes HCV Infection

BOSTON -- A natural compound found in grapefruit may provide a new treatment for hepatitis C, researchers here found. full story

http://www.medpagetoday.com/InfectiousDisease/Hepatitis/tb/9289

C. Difficile Disease Shows Sharp Increase

ATLANTA -- A new and more severe strain of Clostridium difficile may be playing a role in a skyrocketing rate of hospitalization for C. difficile -associated disease (CDAD). full story

http://www.medpagetoday.com/InfectiousDisease/GeneralInfectiousDisease/tb/9287

FDA Says Deliberate Tampering Likely Cause of Heparin Contamination
WASHINGTON -- The most likely explanation for the adulterated heparin that has been linked to 81 deaths was "intentional contamination," an FDA official told Congress. full story

http://www.medpagetoday.com/PublicHealthPolicy/PublicHealth/tb/9285

Progesterone Improves Head Injury Recovery

HANGZHOU, China -- Head injury patients treated with injections of progesterone in an investigational protocol had improved survival and better function after six months in a small randomized trial, researchers here said. full story

http://www.medpagetoday.com/Neurology/HeadTrauma/tb/9278

Flu Study Yields New Way of Making Monoclonal Antibodies

OKLAHOMA CITY -- Human monoclonal antibodies against the flu and, potentially, other infectious diseases, can be quickly made in large quantities in the lab, researchers here said. full story

http://www.medpagetoday.com/InfectiousDisease/URItheFlu/tb/9283

Aspirin Modestly Protects Against Breast Cancer

ROCKVILLE, Md. -- Regular aspirin use may reduce women’s risk of estrogen receptor-positive breast cancer by 16%, according to a prospective cohort study. full story

http://www.medpagetoday.com/HematologyOncology/BreastCancer/tb/9281

FDA Approves Lubiprostone (Amitiza) for Women with IBS with Constipation
ROCKVILLE, Md. -- The FDA has approved lubiprostone (Amitiza) for women 18 or older with irritable bowel syndrome with constipation (IBS-C). full story

http://www.medpagetoday.com/ProductAlert/Prescriptions/tb/9280

CME SPOTLIGHT

Optimizing the Care of Patients with Allergic Rhinitis: An Evidence-Based Approach to Diagnosis and Treatment
Approximately 20 to 40 million people in the US suffer from allergic rhinitis (AR). Many patients however, are undiagnosed. This CME/CE newsletter provides several tools to help simplify the diagnosis and treatment of AR.
Source: Med-IQ [more]

Controversies and Consensus in the Management of HIV: Interactive Debates
Are NNRTI- or PI-based regimens the best choice for initial ARV therapy? If a patient is failing therapy, when should you switch? Do treatment experienced patients require 2 or 3 active ARV agents? Join us for thoughtful debates and lively discussion led by a panel of HIV experts.
Source: AdvancMed [more]

Emerging Trends in the Treatment of Renal Cell Carcinoma
Drs. Michael B. Atkins, Bernard J. Escudier, and Gary R. Hudes lead this CME activity which examines current and evolving standards of care for the treatment of early stage and advanced renal cell carcinoma; best practices for optimal patient outcomes are also covered.
Source: The Physicians Academy For Clinical and Management Excellence [more]

neuroscienceCME Journal Club
Trouble keeping up with the latest findings from the clinical literature? neuroscienceCME Journal Club can help. Hear leading authors talk about just-published articles, and then answer your questions. Hosted by Thomas Roth, PhD.
Source: CME Outfitters [more]

Community-Acquired Pneumonia: Translating Clinical Practice and Management Into Quality Outcomes
Join Dr. Amin for an innovative and in-depth CME-certified Activity on community acquired pneumonia and translating clinical practice and management into quality outcomes.
Source: CME Enterprise [more]

The Evolution and Role of Incretin-Based Therapeutics.
This activity reviews the pathogenesis of type 2 diabetes, the mechanisms by which incretin hormones affect glucose homeostasis, and the role of incretin-based therapeutics in the management of type 2 diabetes.
Source: SciMed New York [more]

A Customized Approach to the Management of Hepatitis B Viral Infection
This CME journal supplement is case-based and provides practical approaches to halting the natural history of HBV infection, to tailoring HBV therapy, and to treating pregnant or immunosuppressed patients infected with HBV.
Source: AdvancMed [more]

Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities
This CME/CE program features state-of-the-science information on hepatitis B virus (HBV) disease burden, HBV replication and transmission, screening for HBV, treatment options and management of HBV.
Source: Projects In Knowledge [more]

Managing the Symptomatic Menopausal Patient in Primary Care: A Case-Based Approach
This interactive CME activity provides practical recommendations and the latest clinical evidence to improve the personalized care a women receives during menopause.
Source: Interstate Postgraduate Medical Association and MEV Healthcom, Inc. [more]

NEEDS ASSESSMENT

Developments in the Field of Advanced Renal Cell Carcinoma
Share your opinion. It matters.

Drs. Robert J. Motzer, Robert A. Figlin, Daniel J. George, and Brian I. Rini invite you to share your opinion in this short survey to help shape the content of an upcoming CME activity on advanced renal cell carcinoma. Thank you in advance for your valuable feedback. Source: Scepter [more]

JOURNAL DOWNLOADS

Efficacy Data for CTCL Published in JCO
Efficacy Data for CTCL Published in JCO. Source: Merck. [more]

First-line SUTENT® data recently published in NEJM
Read first-line SUTENT data in the New England Journal of Medicine. Get it at SUTENThcp.com Source: Pfizer [more]

RESOURCES

Review safety, efficacy and PIs for Pfizer oncology medicines; search clinical trials, review pipeline, and more
Visit PfizerOncology.com to access the latest reprints, slides, and other resources, organized by tumor type; efficacy, safety, and dosing for Pfizer oncology drugs; current oncology news; clinical trials suitable for your patients; and more. Source: Pfizer [more]

Frequently painful. Potentially severe. Learn why your patients maybe be at risk.
Zoster: How Many of your patients are at risk? Source: Merck [more]

Find comprehensive, up-to-date information about clinical trials in oncology with TrialTrove™
Visit www.rocheexchange.com to access TrialTrove™, a real-time global oncology clinical trials database. For your convenience, each trial summary describes the study design, inclusion and exclusion criteria, and where the research is being conducted. Source: Roche [more]

View product information to discover more about sequential therapy in early breast cancer
Efficacy ? Safety ? Dosing ? Key reprints ? Materials and tools ? Easy-to-read prescribing information ? Patient educational materials Source: Pfizer [more]

Featured Job Opportunities from MedJobs Today

Urology, Arkansas
Position consists of clinic, hospital consults, and surgery, and there is ER coverage with a minimum of 10 days per month.
http://www.medjobstoday.com/seeker/job_detail.cfm?jobid=17311&refsrc=dh
Urology, New York
A teaching facility in upstate New York is seeking two urologists to place for clinic and call coverage.
http://www.medjobstoday.com/seeker/job_detail.cfm?jobid=17590&refsrc=dh
Urology, Wisconsin
This opening is for weekend call coverage from Friday evening at 5pm to Monday morning at 8am.
http://www.medjobstoday.com/seeker/job_detail.cfm?jobid=17779&refsrc=dh

Visit MedJobs Today.com to search for a new job!

ASE Meeting

ASE: Nurses Can Do Stress Echocardiograms Safely

ASE: Vascular Ultrasound Finds Unsuspected Arterial Plaque

EASD Meeting

EASD: Insulin Detemir (Levemir) Provides Good Control Long Term

ASCO Breast Meeting

ASCO Breast: Lymphedema Diagnosis Should Take Patient Perception into Account

AGS Meeting

AGS: Protocol-Driven Team Care Improves Health of Low-Income Elderly

AGS: Improper Antihistamine Use Common in Older Adults

Get tools, resources & information about Gleevec matching the experience of attendees of the 2007 ASH Annual Meeting.

Did you miss the Gleevec booth at the 2007 ASH Meeting? Get tools, resources and information about Gleevec via a fully interactive virtual exhibit booth, matching the experience of attendees of the 2007 ASH Annual Meeting.

Source: Novartis Oncology.

At MedPage Today™, we’re PUTTING BREAKING MEDICAL NEWS INTO PRACTICE™.

You have received this email because you have registered to receive alert emails at www.medpagetoday.com, with the email address: delphine1939@videotron.ca. You can easily manage your subscriptions by clicking on the "Edit Profile" link below.

SUBSCRIBE OR UNSUBSCRIBE:
Edit Profile

TECHNICAL QUESTIONS:
webmaster@medpagetoday.com

MedPage Today, LLC.
Overlook at Great Notch
150 Clove Road
Little Falls, New Jersey 07424
Telephone: (973) 890-0985
Fax: (973) 890-1327